Table 3.

Key Messages

1. Allergen immunotherapy is the only treatment that can modify the immune response upon exposure to aeroallergens.

2. Short- and long-term AIT benefits in the asthma treatment are documented.

3. No consensus exists on the optimal endpoints of asthma.

4. Increasing safety and efficiency is the main goal of research for novel immunotherapy development and improvement of treatment in asthma.